TY - JOUR
T1 - Evidence of advanced stage colorectal cancer with longer diagnostic intervals
T2 - a pooled analysis of seven primary care cohorts comprising 11,720 patients in five countries
AU - Tørring, Marie Louise
AU - Murchie, Peter
AU - Hamilton, William
AU - Vedsted, Peter
AU - Esteva, Magdalena
AU - Djernes Lautrup, Marianne
AU - Winget, Marcy
AU - Rubin, Greg
N1 - The CaPri Colorectal Cancer Collaboration project received no formally targeted donations, but, the primary author MLT co-ordinated the work as part of her postdoctoral studies at the Research Centre for Cancer Diagnosis in Primary Care (CaP), funded by the Novo Nordisk Foundation and the Danish Cancer Society. The CRUX study was funded by NHS Grampian Research Endowment Award 11/26, and a grant from The Colorectal Study Fund (a NHS Grampian Endowment fund). The CAPER study was funded by the Department of Health, UK. The CRCDK study was supported by grants from Western Danish Research Forum, Danish Medical Research Council, Dagmar Marshall’s Fund and the Danish Cancer Society. The ALBERTA was funded by the National Cancer Institute of Canada, Alberta Cancer Foundation, and the Canadian Institute of Health Research. The CAP study was supported by the Novo Nordisk Foundation, the Danish Cancer Society, the Health Foundation, the Tryg Foundation, and the Central Denmark Region’s ‘Praksisforskningsfond’. The DECCIRE study was financed with grants from the Ministry of Health, Carlos III Institute, and also received support from the Health Promotion and Preventive Activities-Primary Health-Care Network, sustained by the Ministry of Health in Spain. The NACDPC study was financed by the Department of Health, England. The sponsors were not involved in any part of the studies.
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
PY - 2017/9/5
Y1 - 2017/9/5
N2 - BACKGROUND: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components of the diagnostic interval.
METHODS: We identified seven independent datasets from population-based studies in Scotland, England, Canada, Denmark and Spain during 1997-2010 with a total of 11,720 newly-diagnosed CRC patients, who had initially presented with symptoms to a primary care physician. Data were extracted from patient records, registries, audits and questionnaires, respectively. Datasets were required to hold information on dates in the diagnostic interval (defined as the time from the first presentation of symptoms in primary care until the date of diagnosis), symptoms at first presentation in primary care, route of referral, gender, age and histologically confirmed stage. We carried out reanalysis of all individual datasets and, using the same method, analyzed a pooled individual patient dataset.
RESULTS: The association between intervals and stage was similar in the individual and combined dataset. There was a statistically significant convex (∩-shaped) association between primary care interval and diagnosis of advanced (i.e. distant or regional) rather than localised CRC (P=0.002), with odds beginning to increase from the first day on and peaking at 90 days. For specialist care we saw an opposite and statistically significant concave (∪-shaped) association, with a trough at 60 days, between the interval and diagnosis of advanced CRC (P<0.001).
CONCLUSION: This study provides evidence that longer diagnostic intervals are associated with more advanced CRC. Furthermore, the study cannot define a specific ’safe’ waiting time as the length of the primary care interval appears to have negative impact from day one.
AB - BACKGROUND: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components of the diagnostic interval.
METHODS: We identified seven independent datasets from population-based studies in Scotland, England, Canada, Denmark and Spain during 1997-2010 with a total of 11,720 newly-diagnosed CRC patients, who had initially presented with symptoms to a primary care physician. Data were extracted from patient records, registries, audits and questionnaires, respectively. Datasets were required to hold information on dates in the diagnostic interval (defined as the time from the first presentation of symptoms in primary care until the date of diagnosis), symptoms at first presentation in primary care, route of referral, gender, age and histologically confirmed stage. We carried out reanalysis of all individual datasets and, using the same method, analyzed a pooled individual patient dataset.
RESULTS: The association between intervals and stage was similar in the individual and combined dataset. There was a statistically significant convex (∩-shaped) association between primary care interval and diagnosis of advanced (i.e. distant or regional) rather than localised CRC (P=0.002), with odds beginning to increase from the first day on and peaking at 90 days. For specialist care we saw an opposite and statistically significant concave (∪-shaped) association, with a trough at 60 days, between the interval and diagnosis of advanced CRC (P<0.001).
CONCLUSION: This study provides evidence that longer diagnostic intervals are associated with more advanced CRC. Furthermore, the study cannot define a specific ’safe’ waiting time as the length of the primary care interval appears to have negative impact from day one.
KW - delayed diagnosis
KW - waiting lists
KW - tumour staging
KW - colorectal cancer
KW - primary health care
KW - bias
U2 - 10.1038/bjc.2017.236
DO - 10.1038/bjc.2017.236
M3 - Article
C2 - 28787432
VL - 117
SP - 888
EP - 897
JO - British Journal of Cancer
JF - British Journal of Cancer
SN - 0007-0920
ER -